Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Regeneus Ltd. ( (AU:CMB) ) has shared an announcement.
Cambium Bio Limited, trading on the ASX under the symbol CMB, has issued 4,570,665 ordinary shares without the need for disclosure to investors, as permitted under the Corporations Act 2001. The company confirms compliance with relevant provisions of the Act and states that there is no excluded information requiring disclosure. This move is part of the company’s ongoing regulatory compliance and operational transparency.
More about Regeneus Ltd.
Average Trading Volume: 15,250
Technical Sentiment Signal: Sell
Current Market Cap: A$6.58M
See more data about CMB stock on TipRanks’ Stock Analysis page.